Search Results

Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub.

• Authors : Jung SM; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Loo SL

• Source: PLoS medicine [PLoS Med] 2024 Apr 17; Vol. 21 (4), pp. e1004387. Date of Electronic Publication: 2024 Apr 17.Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Age-specific nasal epithelial responses to SARS-CoV-2 infection.

• Authors : Woodall MNJ; Great Ormond Street UCL Institute of Child Health, London, UK.; Cujba AM

• Source: Nature microbiology [Nat Microbiol] 2024 Apr 15. Date of Electronic Publication: 2024 Apr 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101674869 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Biallelic variants in Plexin B2 ( PLXNB2 ) cause amelogenesis imperfecta, hearing loss and intellectual disability.

• Authors : Smith CEL; Laugel-Haushalter V ...

• Source: Journal of medical genetics [J Med Genet] 2024 Apr 08. Date of Electronic Publication: 2024 Apr 08.Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Print-Electronic Cited Medium: Internet

Record details

"My Dead Body": Development, production, and reception of a documentary that publicly displays the dissection of a human donor.

• Authors : Smith CF; Department of Medical Education, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; Stone D

• Source: Anatomical sciences education [Anat Sci Educ] 2024 Mar 31. Date of Electronic Publication: 2024 Mar 31.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101392205 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Heterozygous COL17A1 variants are a frequent cause of amelogenesis imperfecta.

• Authors : Hany U; Leeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK.; Watson CM

Subjects: Non-Fibrillar Collagens*/Non-Fibrillar Collagens*/Non-Fibrillar Collagens*/genetics ; Non-Fibrillar Collagens*/Non-Fibrillar Collagens*/Non-Fibrillar Collagens*/metabolism ; Amelogenesis Imperfecta*/Amelogenesis Imperfecta*/Amelogenesis Imperfecta*/genetics

• Source: Journal of medical genetics [J Med Genet] 2024 Mar 21; Vol. 61 (4), pp. 347-355. Date of Electronic Publication: 2024 Mar 21.Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

fNIRS is capable of distinguishing laterality of lower body contractions.

• Authors : MacLennan RJ; University of Florida, Gainesville, USA.; Hernandez-Sarabia JA

• Source: Experimental brain research [Exp Brain Res] 2024 Mar 14. Date of Electronic Publication: 2024 Mar 14.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0043312 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

flepiMoP: The evolution of a flexible infectious disease modeling pipeline during the COVID-19 pandemic.

• Authors : Lemaitre JC; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: .; Loo SL

• Source: Epidemics [Epidemics] 2024 Mar 02; Vol. 47, pp. 100753. Date of Electronic Publication: 2024 Mar 02.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101484711 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The US COVID-19 and Influenza Scenario Modeling Hubs: Delivering long-term projections to guide policy.

• Authors : Loo SL; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; International Vaccine Access Center, Johns Hopkins, Baltimore, MD, USA. Electronic address: .

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; Influenza, Human*/Influenza, Human*/Influenza, Human*/epidemiology; Humans

• Source: Epidemics [Epidemics] 2024 Mar; Vol. 46, pp. 100738. Date of Electronic Publication: 2023 Dec 29.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101484711 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa.

• Authors : Lau CH; Epithelial Cell Biology in ENT Research (EpiCENTR) Group, UCL Great Ormond Street Institute of Child Health, University College London, 20c Guilford Street, London WC1N 1DZ, UK.; Rouhani MJ

• Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Feb 29. Date of Electronic Publication: 2024 Feb 29.Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.

• Authors : Standing JF; PANORAMIC Virology Group

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19* ; Hydroxylamines*

• Source: Nature communications [Nat Commun] 2024 Feb 23; Vol. 15 (1), pp. 1652. Date of Electronic Publication: 2024 Feb 23.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details